Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOXIe: Omaveloxolone in Friedreich's Ataxia
NCT02255435Phase 2Completed
- Sponsor
- Biogen
- Start
- Jan 2015
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of omaveloxolone in Friedreich's ataxia (FA), sponsored by Biogen. Started Jan 2015; status: completed.
02
Drugs
omaveloxolone
03
Conditions
Friedreich's ataxia (FA)
Beyond the preview
Go deeper on NCT02255435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02255435.